Fleseriu M, Hashim IA, Karavitaki N, et al. Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2016;101(11):3888-3921.
[2]
Higham CE, Johannsson G, Shalet SM. Hypopituitarism. Lancet. 2016;388(10058):2403-2415.
[3]
Kreutzer J, Vance ML, Lopes MB, Laws ER Jr. Surgical management of GH-secreting pituitary adenomas: an outcome study. J Clin Endocrinol Metab. 2001;86(9):4072-4077.
[4]
Molitch ME. Diagnosis and Treatment of Pituitary Adenomas: A Review. JAMA. 2017;317(5):516-524.
[5]
van der Klaauw AA, Biermasz NR, Feskens EG, et al. The prevalence of the metabolic syndrome is increased in patients with hypopituitarism regardless of the long-term optimal replacement therapy. Eur J Endocrinol. 2006;154(1):89-97.